Report Feature
The future of the pharmacokinetic service market looks promising with opportunities in the hospitals and pharmaceutical companies. The global pharmacokinetic service market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are to reduce concerns about high drug attrition and enable early identification of potential challenge.
A total of XX figures / charts and XX tables are provided in more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global pharmacokinetic service market report, please download the report brochure.
In this market, small molecules pharmacokinetic service is the largest drug type of pharmacokinetics service. Growth in various segments of the pharmacokinetic market are given below:
The study includes trends and forecast for the global pharmacokinetic service market by drug type, end user, and region as follows:
By Drug Type [Value ($ Million) shipment analysis for 2014 – 2025]:
- Small Molecule Pharmacokinetic Services
- Large Molecule (Biopharmaceutical) Pharmacokinetic Services
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Hospitals
- Pharmaceutical Companies
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Spain
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the pharmacokinetic service companies profiled in this report include Evotec, Certara, Pacific BioLab, GVK Biosciences, Shanghai Medicilon, Pharmaceutical Product Development, Charles River Laboratories International, PAREXEL International Corporation, Eurofins Scientific, and Frontage Labs.
Lucintel forecasts that small molecule pharmacokinetic services will remain the largest drug type segment over the forecast period due to increasing emphasize on studying molecule of smaller atomic weight and drug metabolism.
North America will remain the largest region, and it is also expected to witness the highest growth over the forecast period due to the presence of a large number prominent pharmaceutical companies in the region and presence of effective regulatory structure pertaining to drug development processes including PKPD (pharmacokinetic and pharmacodynamic determinant) and toxicology studies in the region.
|
Features of the Global Pharmacokinetic Service Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global pharmacokinetic service market by drug type (small molecule pharmacokinetic services and large molecule (biopharmaceutical) pharmacokinetic), end user (hospitals and pharmaceutical companies), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global pharmacokinetic service market? Q.5 What are the business risks and threats to the global pharmacokinetic service market? Q.6 What are the emerging trends in this pharmacokinetic service market and the reasons behind them? Q.7 What are some changing demands of customers in this pharmacokinetic service market? Q.8 What are the new developments in this pharmacokinetic service market? Which companies are leading these developments? Q.9 Who are the major players in this pharmacokinetic service market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this pharmacokinetic service market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global pharmacokinetic service market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Drug Type (Small Molecule Pharmacokinetic Services and Large Molecule (Biopharmaceutical) Pharmacokinetic), and End User (Hospitals and Pharmaceutical Companies) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
4.1 Global Pharmacokinetic Service Market by Region
4.2.1 Market by Drug Type: Small Molecule Pharmacokinetic Services and Large Molecule (Biopharmaceutical) Pharmacokinetic Services
4.2.2 Market by End User: Hospitals and Pharmaceutical Companies
4.2.3 The United States Pharmacokinetic Service Market
4.2.4 The Canadian Pharmacokinetic Service Market
4.2.5 The Mexican Pharmacokinetic Service Market
4.3.1 Market by Drug Type: Small Molecule Pharmacokinetic Services and Large Molecule (Biopharmaceutical) Pharmacokinetic Services
4.3.2 Market by End User: Hospitals and Pharmaceutical Companies
4.3.3 The United Kingdom Pharmacokinetic Service Market
4.3.4 The Spanish Pharmacokinetic Service Market
4.3.5 The German Pharmacokinetic Service Market
4.3.6 The French Pharmacokinetic Service Market
4.4.1 Market by Drug Type: Small Molecule Pharmacokinetic Services and Large Molecule (Biopharmaceutical) Pharmacokinetic Services
4.4.2 Market by End User: Hospitals and Pharmaceutical Companies
4.4.3 The Chinese Pharmacokinetic Service Market
4.4.4 The Indian Pharmacokinetic Service Market
4.4.5 The Japanese Pharmacokinetic Service Market
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
